Finance

Lists
B1SX34:BVMF
Boston Scientific Corp Brazilian Depositary Receipt
R$ 53.00
-0.53%
(-0.28) 1D
10-р сарын 6, 17:10:00 (GMT-3)  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for B1SX34...
Open
R$ 53.20
High
R$ 53.20
Low
R$ 52.35
Mkt. cap
61.43 тэрбум
Avg. vol.
1.09 мян
Volume
0.00
52-wk high
R$ 140.91
52-wk low
R$ 50.29
Shares outstanding
1.45 тэрбум
No. of employees
59 мян
Open
R$ 53.20
High
R$ 53.20
Low
R$ 52.35
Mkt. cap
61.43 тэрбум
Avg. vol.
1.09 мян
Volume
0.00
52-wk high
R$ 140.91
52-wk low
R$ 50.29
Shares outstanding
1.45 тэрбум
No. of employees
59 мян
News stories
From web sources and news partners
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp Brazilian Depositary Receipt
CEOMichael F. Mahoney
Employees59 мян
Founded1979 оны 6-р сарын 29
HeadquartersMarlborough, Массачусеттс, Америкийн Нэгдсэн Улс
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
5.06 тэрбум
5.29 тэрбум
5.20 тэрбум
5.44 тэрбум
Cost of goods sold
1.54 тэрбум
1.61 тэрбум
1.60 тэрбум
1.61 тэрбум
Cost of revenue
1.54 тэрбум
1.61 тэрбум
1.60 тэрбум
1.61 тэрбум
Research and development expenses
514.00 сая
569.00 сая
516.00 сая
554.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74 тэрбум
1.83 тэрбум
1.78 тэрбум
1.80 тэрбум
Operating expense
2.48 тэрбум
2.63 тэрбум
2.53 тэрбум
2.59 тэрбум
Total operating expenses
4.02 тэрбум
4.24 тэрбум
4.13 тэрбум
4.20 тэрбум
Operating income
1.05 тэрбум
1.04 тэрбум
1.07 тэрбум
1.25 тэрбум
Other non operating income
-16.00 сая
28.00 сая
28.00 сая
-6.00 сая
EBT including unusual items
938.00 сая
700.00 сая
1.16 тэрбум
1.06 тэрбум
EBT excluding unusual items
935.00 сая
1.01 тэрбум
999.00 сая
1.14 тэрбум
Income tax expense
183.00 сая
30.00 сая
-176.00 сая
155.00 сая
Effective tax rate
19.51%
4.29%
-15.13%
14.62%
Other operating expenses
-
-
-
-
Net income
755.00 сая
672.00 сая
1.34 тэрбум
907.00 сая
Net profit margin
14.91%
12.71%
25.77%
16.67%
Earnings per share
0.75
0.80
0.80
0.86
Interest and investment income
-
29.00 сая
-
11.00 сая
Interest expense
-87.00 сая
-90.00 сая
-90.00 сая
-96.00 сая
Net interest expenses
-87.00 сая
-61.00 сая
-90.00 сая
-85.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.39 тэрбум
1.41 тэрбум
1.42 тэрбум
1.60 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс